Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates
Abstract 211At is a most promising radionuclide for targeted alpha therapy. However, its limited availability and poorly known basic chemistry hamper its use. Based on the analogy with iodine, labelling is performed via astatobenzoate conjugates, but in vivo deastatination occurs, particularly when...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ed78f40f24454144bfa69cd69a69a850 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|